Literatur
Ferrari MD et al. Migraine. Nat Rev Dis Primers. 2022;8:2
Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002;346:257-70
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3. Edition. Cephalalgia. 2018;38:1-211
Terwindt GM et al. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55:624-9
Steiner TJ et al. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21:137
Bille B. 40-year follow-up of school children with migraine. Cephalalgia. 1997;17:488-91
Gormley P et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48:856-66
Lipton RB et al. Methodological issues in studying trigger factors and premonitory features of migraine. Headache. 2014;54:1661-9
Stubberud A et al. Is there a causal relationship between stress and migraine? Current evidence and implications for management. J Headache Pain. 2021;22:155
Borkum JM. Migraine triggers and oxidative stress. Headache. 2016;56:12-35
Fila M et al. Nutrients to improve mitochondrial function to reduce brain energy deficit and oxidative stress in migraine. Nutrients. 2021;13
Gross EC et al. The metabolic face of migraine - from pathophysiology to treatment. Nat Rev Neurol. 2019;15:627-43
Göbel H et al. Healthcare behavior of migraine and headache patients when treatment is accompanied by the digital migraine app. Schmerz. 2019;33:147-55
Göbel H et al. Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders. Schmerz. 2014;28:191-204
Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12:570-84
Maniyar FH et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137:232-41
Schain AJ et al. Activation of pial and dural macrophages and dendritic cells by cortical spreading depression. Ann Neurol. 2018;83:508-21
Schain AJ et al. Cortical spreading depression closes paravascular space and impairs glymphatic flow: implications for migraine headache. J Neurosci. 2017;37:2904-15
Zhang X et al. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010;30:8807-14
Edvinsson L et al. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol. 2018;14:338-50
Knight YE, Edvinsson L, Goadsby PJ. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity? Neuropharmacology. 2001;40:520-5
Ashina M. Migraine. NEJM. 2020; 383:1866-76
Drellia K et al. Anti-CGRP monoclonal antibodies for migraine prevention. Cephalalgia. 2021;41:851-64
Forbes RB, Mccarron M, Cardwell CR. Efficacy and contextual (placebo) effects of CGRP antibodies for migraine. Headache. 2020;60:1542-57
Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123 (Pt 8):1703-9
May A. New insights into headache: an update on functional and structural imaging findings. Nat Rev Neurol. 2009;5:199-209
Goadsby PJ et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553-622
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Göbel, C., Küster, M., Horlemann, J. et al. Klinische Manifestationen und Pathophysiologie der Migräne. Schmerzmed. 38, 20–27 (2022). https://doi.org/10.1007/s00940-022-4039-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00940-022-4039-3